Abstract
A puppy was diagnosed with lymphangiosarcoma associated with lymphedema based on lymphogi and histopathology. The lesions resolved after toceranib therapy, and the dog remains in remission 1 year This is the first report of a successful outcome following oral toceranib as first-line therapy for lymphangiosan in a dog.
| Original language | English |
|---|---|
| Pages (from-to) | 367-372 |
| Number of pages | 6 |
| Journal | Canadian Veterinary Journal |
| Volume | 59 |
| Issue number | 4 |
| State | Published - 2018.04 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver